COVID-19 vaccines and multiple sclerosis disease-modifying therapies
Gavin Giovannoni, Christopher H. Hawkes, Jeannette Lechner‐Scott, Michael Levy, E. Ann Yeh, David Baker
Topics & Concepts
MedicineOcrelizumabMultiple sclerosisRituximabPandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseFingolimodVirologyInfectious disease (medical specialty)ImmunologyPathologyLymphomaOutbreakSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesImmunotherapy and Immune Responses